Evidence suggests that elevated serum levels of RANKL in CN patients can enhance osteogenic differentiation and mineralization of vascular smooth muscle cells (Ndip et al., 2011), which can eventually aggravate the ischemic necrotic lesion of the limb. The gene discussed is TNFSF11; the disease is cyclic hematopoiesis.